Dalton King

1.5k citations

26 papers · 1.0k indexed · h-index 17

Impact in

Radiology, Nuclear Medicine and Imaging top 5%
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
Oncology top 10%
- HER2/EGFR in Cancer Research

Papers in ⓘ

Molecular Biology 18
- Chemical Synthesis and Analysis 5
- Advanced biosensing and bioanalysis techniques 3
- Phenothiazines and Benzothiazines Synthesis and Activities 3
Organic Chemistry 9
- Synthesis and Biological Evaluation 3

Co-authors: Raymond A. Firestone (9 shared papers)Pamela A. Trail (8 shared papers)Shirley J. Lasch (7 shared papers)David Willner (6 shared papers)Sandra J. Hofstead (5 shared papers)Gene M. Dubowchik (5 shared papers)Gary R. Braslawsky (3 shared papers)Robert S. Greenfield (3 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (10 papers)Tetrahedron Letters (2 papers)Bioconjugate Chemistry (2 papers)PLoS ONE (2 papers)Journal of Medicinal Chemistry (2 papers)
Partner nations: United States Germany Switzerland

In The Last Decade

Dalton King

26 papers receiving 985 citations

Peers

Countries citing papers authored by Dalton King

Since Specialization

Citations

This map shows the geographic impact of Dalton King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalton King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalton King more than expected).

Fields of papers citing papers by Dalton King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalton King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalton King. The network helps show where Dalton King may publish in the future.

Co-authors

The 25 scholars most cited alongside Dalton King, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dalton King Line = papers co-authored together Dalton King links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluations. Proceedings of the National Academy of Sciences ·John D. Rodwell, Vernon L. Alvarez, C Lee, A.Dwight Lopes, John Goers, Dalton King, H J Powsner, Thomas J. McKearn	1986	189
2	(6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicin Bioconjugate Chemistry ·David Willner, Pamela A. Trail, Sandra J. Hofstead, Dalton King, Shirley J. Lasch, Gary R. Braslawsky, Robert S. Greenfield, Takushi Kaneko, Raymond A. Firestone	1993	183
3	Enantioselective Synthesis of a Highly Potent Selective Serotonin Reuptake Inhibitor. An Application of Imidazolidinone Catalysis to the Alkylation of Indoles with an α,β-Disubstituted α,β-Unsaturated Aldehyde Organic Letters ·Dalton King, Zhaoxing Meng, Derek J. Denhart, Ronald J. Mattson, Roy Kimura, Dedong Wu, Qi Gao, John E. Macor	2005	102
4	Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Peptide Linkers: Inhibition of Aggregation by Methoxytriethyleneglycol Chains Journal of Medicinal Chemistry ·Dalton King, Gene M. Dubowchik, Harold Mastalerz, David Willner, Sandra J. Hofstead, Raymond A. Firestone, Shirley J. Lasch, Pamela A. Trail	2002	100
5	Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Linkers: A Novel Method for Increasing the Potency of Doxorubicin Immunoconjugates Bioconjugate Chemistry ·Dalton King, Derek Yurgaitis, David Willner, Raymond A. Firestone, Michael B. Yang, Shirley J. Lasch, Karl Erik Hellström, Pamela A. Trail	1999	60
6	Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates. PubMed ·Pamela A. Trail, David Willner, Jay O. Knipe, Arris J. Henderson, Shirley J. Lasch, Mary Zoeckler, Mark D. TrailSmith, Terrence W. Doyle, Dalton King, Anna Maria Casazza, Gary R. Braslawsky, Joseph Brown, Sandra J. Hofstead, Robert S. Greenfield, Raymond A. Firestone, Kathleen Mosure, Kathleen F. Kadow, Michael B. Yang, Karl Erik Hellström, Ingegerd Hellström	1997	45
7	Doxorubicin immunoconjugates containing bivalent, lysosomally-Cleavable dipeptide linkages Bioorganic & Medicinal Chemistry Letters ·Gene M. Dubowchik, Shilpa Radia, Harold Mastalerz, Michael Walker, Raymond A. Firestone, Dalton King, Sandra J. Hofstead, David Willner, Shirley J. Lasch, Pamela A. Trail	2002	30
8	Synthesis and antitumor activity of the immunoconjugate BR96-Dox Journal of Controlled Release ·Raymond A. Firestone, David Willner, Sandra J. Hofstead, Dalton King, Takushi Kaneko, Gary R. Braslawsky, Robert S. Greenfield, Pamela A. Trail, Shirley J. Lasch, Arris J. Henderson, Anna Maria Casazza, Ingegerd Hellström, K E Hellström	1996	27
9	Aminotriazine 5-HT7 antagonists Bioorganic & Medicinal Chemistry Letters ·Ronald J. Mattson, Derek J. Denhart, John D. Catt, Michael F. Dee, Jeffrey A. Deskus, Jonathan L. Ditta, James R. Epperson, Dalton King, Aiming Gao, Michael A. Poss, Ashok V. Purandare, David R. Tortolani, Yufen Zhao, Hua Yang, Suresh Yeola, Jane M. Palmer, John R. Torrente, Arlene Stark, Graham Johnson	2004	26
10	Interactions of some novel amide-linked bis(acridines) with deoxyribonucleic acid Biochemistry ·Dalton King, W. David Wilson, Edmond J. Gabbay	1982	26
11	Synthesis and release of doxorubicin from a cephalosporin based prodrug by a β-lactamase-immunoconjugate Bioorganic & Medicinal Chemistry Letters ·Thomas W. Hudyma, Karen Bush, Kimberly L. Colson, Raymond A. Firestone, Dalton King	1993	26
12	Chemical Modification of Linkers Provides Stable Linker–Payloads for the Generation of Antibody–Drug Conjugates ACS Medicinal Chemistry Letters ·Yam B. Poudel, Naidu S. Chowdari, Heng Cheng, Christiana Iwuagwu, Dalton King, Srikanth Kotapati, David Passmore, Richard Rampulla, Arvind Mathur, Gregory D. Vite, Sanjeev Gangwar	2020	26
13	Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors Bioorganic & Medicinal Chemistry Letters ·Derek J. Denhart, Jeffrey A. Deskus, Jonathan L. Ditta, Qi Gao, Dalton King, Edward S. Kozlowski, Zhaoxing Meng, Melissa A. LaPaglia, Gail K. Mattson, Thaddeus F. Molski, Matthew T. Taber, Nicholas J. Lodge, Ronald J. Mattson, John E. Macor	2009	24
14	Facile synthesis of maleimide bifunctional linkers Tetrahedron Letters ·Dalton King, Gene M. Dubowchik, Michael Walker	2002	21
15	Conformationally restricted homotryptamines. Part 4: Heterocyclic and naphthyl analogs of a potent selective serotonin reuptake inhibitor Bioorganic & Medicinal Chemistry Letters ·Dalton King, Derek J. Denhart, Jeffrey A. Deskus, Jonathan L. Ditta, James R. Epperson, Mendi A. Higgins, Joyce E. Kung, Lawrence R. Marcin, C.P. Sloan, Gail K. Mattson, Thaddeus F. Molski, Rudolph G. Krause, Robert L. Bertekap, Nicholas J. Lodge, Ronald J. Mattson, John E. Macor	2007	19
16	The qEEG Signature of Selective NMDA NR2B Negative Allosteric Modulators; A Potential Translational Biomarker for Drug Development PLoS ONE ·Deborah Keavy, Linda J. Bristow, Digavalli V. Sivarao, Margaret Batchelder, Dalton King, Srinivasan Thangathirupathy, John E. Macor, Michael R. Weed	2016	17
17	Synthesis of water-Soluble prodrugs of BMS-191011: A maxi-K channel opener targeted for post-stroke neuroprotection Bioorganic & Medicinal Chemistry Letters ·Piyasena Hewawasam, Min Ding, Nathan Chen, Dalton King, Jay O. Knipe, Lorraine Pajor, Astrid Ortiz, Valentin K. Gribkoff, John E. Starrett	2003	17
18	BR96 conjugates of highly potent anthracyclines Bioorganic & Medicinal Chemistry Letters ·Dalton King, Andrew J. Staab, Kahnie Pham-Kaplita, Derek Yurgaitis, Raymond A. Firestone, Shirley J. Lasch, Pamela A. Trail	2003	16
19	Negative Allosteric Modulators Selective for The NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains Neuropsychopharmacology ·Michael R. Weed, Mark Bookbinder, Joseph Polino, Deborah Keavy, Rudolf N. Cardinal, Jean Simmermacher-Mayer, Fu-ni L Cometa, Dalton King, Srinivasan Thangathirupathy, John E. Macor, Linda J. Bristow	2015	15
20	Monoclonal antibody mediated intracellular targeting of tallysomycin S10b Bioorganic & Medicinal Chemistry Letters ·Michael Walker, Dalton King, R. A. Dalterio, Pamela A. Trail, Raymond A. Firestone, Gene M. Dubowchik	2004	14

About Dalton King

Dalton King is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging, having authored 26 papers that have together received 1.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), Peptidase Inhibition and Analysis (6 papers), Chemical Synthesis and Analysis (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers), Advanced biosensing and bioanalysis techniques (3 papers), Synthesis and Biological Evaluation (3 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (436 citations), Oncology (314 citations), Organic Chemistry (294 citations), Biomaterials (117 citations) and Molecular Biology (463 citations). Dalton King has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Raymond A. Firestone, Pamela A. Trail, Shirley J. Lasch, David Willner, Sandra J. Hofstead, Gene M. Dubowchik, Gary R. Braslawsky, Robert S. Greenfield, John Goers and Vernon L. Alvarez. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Bioconjugate Chemistry, PLoS ONE and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact